Your Health Questions
Answered by Professionals

Pregnancy’s higher estrogen and a Th2 immune shift often thicken hair and can improve alopecia areata, but after delivery the hormone drop and immune rebound commonly cause diffuse shedding 2–4 months postpartum (telogen effluvium, usually resolving within 6–12 months) and can trigger AA flares; female pattern hair loss is less affected and may be unmasked after birth. There are several factors to consider—your alopecia type, timing, and which treatments are safe in pregnancy or breastfeeding—see the complete guidance below to understand key risks, timelines, and the best next steps to discuss with your clinician.

Steroid injections are an effective first-line treatment for patchy alopecia areata: about 60% of patients see significant regrowth after 3–4 sessions, with the best results in small, recent patches. Results are often partial and not permanent, and recurrence is common—important details on who benefits most, expected timelines, side effects, and combination options are covered below.

Ruxolitinib cream is effective for eczema: in an 8‑week trial, about 33% of patients were clear or almost clear and 45% reached EASI‑75, with itch relief often beginning by 2 weeks. For alopecia areata, early studies suggest modest regrowth (around 40% achieving SALT‑50 by 24 weeks), with better results in small, recent patches; it’s generally well tolerated with minimal systemic absorption. There are several factors that can change outcomes—disease extent, duration, adherence, and combination strategies—see below for important details and next steps before deciding if it’s right for you.

Hair loss can spread slowly or rapidly depending on the cause: pattern hair loss usually progresses over years (often 10–20), telogen effluvium begins 6–12 weeks after a trigger with shedding up to 300–500 hairs/day for 3–6+ months, alopecia areata can appear in days to weeks, and scarring types advance over months–years and may be permanent without early treatment. There are several factors to consider—your hair-growth cycle, triggers and systemic illness, and red flags—so see below for full timelines, monitoring tips, treatments, and when to seek care, as these details could change your next steps.

Dermatologists diagnose alopecia by combining a detailed medical and family history with a scalp/hair exam (including pull tests), trichoscopy, targeted blood tests (e.g., thyroid, iron, hormones), and—when needed—a scalp biopsy to distinguish scarring from non-scarring causes. The pattern is then classified (alopecia areata, androgenetic, telogen effluvium, scarring) to guide next steps. There are several factors to consider—see below for what each test shows, when urgent symptoms warrant care, pitfalls to avoid, and how results shape treatment options.

Severity in alopecia areata is graded using the SALT score (0–100%), which quantifies percent scalp hair loss across four regions and maps to S0–S5: S0=0%, S1=1–24%, S2=25–49%, S3=50–74%, S4=75–99%, S5=100% (alopecia totalis; universalis if brows/lashes also lost). There are several factors to consider—eyebrow/eyelash loss and nail changes can increase overall impact and guide treatment choices; see details below that could affect your next steps.

Most people notice new growth within 3–6 months and fuller results by 6–12 months, but timing varies by cause—telogen effluvium often recovers within a year, pattern hair loss responds to treatments over 6–12 months, and alopecia areata can be unpredictable and take longer. There are several factors to consider—age, nutrition, stress, scalp health, and treatment consistency—and certain symptoms warrant prompt care; see complete timelines, month-by-month expectations, and red flags below.

Alopecia treatment timelines vary widely: fine regrowth can start in 6–12 weeks, noticeable results often take 3–6 months, and severe or long‑standing cases can need 9–12 months or longer, often with maintenance to prevent relapse. Outcomes depend on the alopecia type, how long you’ve had it, the extent of loss, age/health, stress, and the therapy used (topical/intralesional steroids, minoxidil, contact immunotherapy, or JAK inhibitors). There are several factors and key decision points (including when to switch or combine treatments) that can affect your next steps—see the full timelines and guidance below.

There are several factors to consider: alopecia areata is a common cause of patchy teen hair loss, but other conditions (tinea capitis, telogen effluvium, traction, trichotillomania, nutritional issues) should be ruled out by a clinician. Management is usually dermatologist-directed (topical/intralesional steroids first; topical immunotherapy, brief oral steroids, or newer options like JAK inhibitors for extensive disease) plus gentle hair care, nutrition and stress support, cosmetic aids, and prompt care for rapid spread, infection signs, nail/eyelash involvement, or distress—see the complete guidance below.

Alopecia can be temporary or permanent—there are several factors to consider; see below for details. Non-scarring types (like telogen effluvium and many cases of alopecia areata) often regrow, while scarring alopecias and advanced pattern hair loss are usually permanent. Early evaluation and treatment can slow progression and sometimes restore hair, so review the guidance below to choose the right next steps.

Yes—thyroid dysfunction can directly cause diffuse "thyroid hair loss," and autoimmune thyroid diseases (Hashimoto's, Graves') frequently coexist with alopecia areata; about 15–25% of people with alopecia areata have thyroid disease or antibodies. Distinguishing patchy bald spots from uniform thinning and knowing when to order TSH, free T4/T3, and antibody tests can change treatment and next steps; there are several factors to consider. See below for the complete answer, including symptoms to watch for, testing, treatment options, and when to seek urgent care.

Yes—anxiety is common with hair loss: roughly one-third of people with alopecia report clinically significant anxiety, and in alopecia areata, studies suggest up to half may experience moderate to severe anxiety. It’s driven by changes in identity, self-esteem, and social concerns, but effective medical and mental health strategies can help. There are several factors to consider; see below for the key causes, symptoms to watch for, and evidence-based next steps and supports.

Side effects of alopecia treatments vary by option: minoxidil can cause scalp irritation, unwanted facial/body hair, temporary shedding, and rarely rapid heartbeat, dizziness, or swelling; finasteride/dutasteride may lead to sexual dysfunction, mood changes, and breast tenderness; steroids can thin skin or (by mouth) cause weight gain, high blood pressure/sugar, infection risk, and adrenal suppression; contact immunotherapy/anthralin often provoke dermatitis; JAK inhibitors raise infection and lab-abnormality risks; and hair transplants carry pain, infection, scarring, and “shock loss.” There are several factors to consider—see below for complete side-effect lists, comparisons (e.g., dutasteride vs finasteride), monitoring and dosing guidance, and urgent red flags (chest pain, severe rash, mood changes, persistent sexual side effects) that should prompt stopping treatment and calling your doctor.

Early signs include sudden, small round, smooth bald patches (on the scalp, eyebrows/eyelashes, beard, or body), fragile “exclamation mark” hairs, brief itching/burning/tingling, nail pitting or ridging (sometimes splits or white spots), and rapid shedding; new hairs may initially grow back fine or white. There are several factors to consider that can influence diagnosis and treatment timing—see below for key details and when to seek care.

Common treatments include topical minoxidil and (for men) oral finasteride for pattern hair loss. Alopecia areata is typically managed with intralesional/topical corticosteroids, topical immunotherapy, or oral JAK inhibitors, while telogen effluvium focuses on correcting triggers (thyroid/iron/nutrition, medication review) with optional short‑term minoxidil; adjuncts like low‑level laser therapy, platelet‑rich plasma, hair transplantation, and cosmetic options can help. The best choice depends on type and severity—important details on dosing, side effects, timelines, and when to seek care are below.

It’s driven by an autoimmune attack on hair follicles in genetically susceptible people, with flare‑ups often triggered by infections, significant stress, skin trauma, or hormonal changes. There are several factors to consider—immune pathways, coexisting autoimmune disease (like thyroid issues), microbiome and nutrition influences, and how it’s distinguished from other hair loss—which can affect diagnosis and treatment; see the complete details below to help plan next steps.

Autoimmune hair loss (most often alopecia areata) happens when the immune system—especially autoreactive CD8+ T cells—mistakenly attacks hair follicles after a collapse of their normal immune privilege, on a background of genetic susceptibility and triggers like infections, psychological stress, skin injury, or chemical irritants. It often coexists with other autoimmune diseases (e.g., thyroid disease, vitiligo), which can shape testing and treatment—there are several factors to consider; see below for crucial details on signs, diagnosis, therapies, and when to seek care.

Alopecia areata patches are smooth, well-defined round or oval bald spots with normal-colored skin and no scaling or scarring, appearing on the scalp or any hair-bearing area and ranging from a few millimeters to several centimeters; they may be single or multiple. Up close (often with magnification), you can see clues like short “exclamation-mark” hairs at the edges, black dots (broken hairs), yellow dots (keratin/sebum), and fine vellus regrowth. There are several factors to consider—such as how to tell it from infection or scarring hair loss and when to seek evaluation or testing—so see below for key visuals, patterns, and next steps that could guide your care.

Habits that can worsen hair loss include poor nutrition (low iron, vitamin D, zinc, inadequate protein/calories), tight or heavy hairstyles/extensions that pull on roots, frequent chemical or heat treatments, harsh or improper care (over- or under-washing, aggressive brushing/towel-drying), and lifestyle risks like chronic stress, smoking, heavy alcohol use, poor sleep, and inactivity; certain medications and conditions (thyroid issues, autoimmune disease, scalp infections) also contribute. There are several factors to consider—see below for practical fixes, which labs to check, safer styling and grooming tips, how to address stress and other habits, medication and health-condition reviews, and the warning signs that mean you should see a doctor.

Alopecia areata is an autoimmune condition where the immune system attacks hair follicles, leading to sudden, smooth round or oval patches of hair loss on the scalp, face, or body; it can occur at any age and affects about 2% of people. There are several factors to consider—triggers, who’s at risk, key signs (including nail changes), diagnosis, prognosis, and treatments from steroids to newer JAK inhibitors—that can influence your next steps; see the complete details below.

Ophiasis pattern alopecia is a subtype of alopecia areata marked by a snake-like, band of hair loss along the sides (temporal) and lower back (occipital) of the scalp due to autoimmune attack on hair follicles. It often has a more persistent course and can be harder to treat than typical patchy alopecia areata—there are several factors to consider. See below for important details that could influence your next steps, including triggers, diagnosis, treatment options, and prognosis.

Trichoscopy is a non-invasive exam of the scalp and hair using a lighted magnifier (dermoscope) to visualize microscopic hair-shaft and scalp changes, helping clinicians differentiate causes of hair loss (e.g., alopecia areata, pattern hair loss, telogen effluvium, scarring alopecias) and often avoid a biopsy. There are several factors to consider, including what it can and can’t show, how to prepare, and red‑flag symptoms that need urgent care—see below for complete details that may guide your next steps.

Medications linked to hair thinning include chemotherapy and immunosuppressants; anticoagulants (heparin, warfarin); cholesterol and cardiovascular drugs (statins, beta-blockers, ACE/ARBs); retinoids (isotretinoin); antidepressants, mood stabilizers, and some antiepileptics (lithium, valproate); hormonal and thyroid therapies; plus certain NSAIDs, PPIs, antifungals, and antiretrovirals. They can disrupt the hair-growth cycle—causing telogen effluvium (often 2–4 months after starting) or anagen effluvium (sooner)—and shedding often improves within months after adjusting or stopping the trigger. There are several factors to consider; see below for key details on timing, alternatives, supportive treatments, and when to seek urgent care.

Resources include professional mental-health care (CBT/ACT with psychologists, psychiatrists, and integrated dermatology-psychology clinics), peer support via NAAF and Alopecia UK, online communities, teletherapy platforms, self-help tools (mindfulness, exercise, journaling), educational sites, and support from family/friends; a free online symptom check can also help you prepare for visits. There are several factors to consider—specific organizations/apps, how to choose the right support, and red flags that require urgent help are detailed below.

Hair loss is evaluated with a clinical exam plus noninvasive scalp/hair tests (pull and tug tests, standardized wash counts, trichoscopy, and sometimes phototrichograms), targeted blood tests (CBC, iron/ferritin, thyroid, selected hormone panels, vitamin D/B12/zinc, autoimmune markers), and fungal studies when indicated. If the cause remains unclear or scarring is suspected, doctors may perform a 4‑mm scalp punch biopsy with vertical and/or horizontal sections to confirm the diagnosis. There are several factors to consider—see below for which tests apply to your situation and the important details that can impact your next steps.

Alopecia types include non-scarring (often reversible) forms—such as androgenetic (male/female pattern), alopecia areata (including totalis/universalis), telogen and anagen effluvium, traction alopecia, trichotillomania, tinea capitis, and alopecia mucinosa—and scarring (cicatricial, permanent) forms like lichen planopilaris/frontal fibrosing alopecia, discoid lupus of the scalp, and central centrifugal cicatricial alopecia; rare congenital types include atrichia with papular lesions and hypotrichosis. There are several important distinctions that affect diagnosis and treatment—see details below on patterns, causes, reversibility, and when to seek urgent care, which can guide your next steps.

A scalp biopsy is recommended when the cause of hair loss remains unclear after initial evaluation (history, exam, dermoscopy, and labs), when scarring alopecia is suspected (smooth shiny patches, burning/itching, pustules), when the pattern is atypical or rapidly progressive, when treatment fails after 3–6 months, or when infections or autoimmune conditions (e.g., tinea, lupus, lichen planopilaris) are suspected. Timing matters: the highest yield comes from an active, minimally treated area—ideally within weeks of onset—taken at the edge of a lesion. There are several factors to consider; see below for key nuances on indications, optimal timing and site, alternatives, benefits/risks, and how these details can guide your next steps.

Alopecia areata often comes back because the autoimmune attack on hair follicles can re-ignite due to persistent “immune memory” and loss of follicle immune privilege, influenced by genetic susceptibility and triggers like stress, infections, hormonal shifts, or nutrient deficiencies. Relapse risk is higher with extensive initial loss, nail changes, early onset, or coexisting autoimmune disease. There are several factors to consider—see below for key triggers, risk factors, and practical steps to monitor, prevent, and treat recurrences with your clinician.

Hair regrowth can stop when the hair cycle is disrupted by telogen effluvium from stress or illness, genetic/hormonal factors like DHT-driven pattern hair loss, autoimmune attack (alopecia areata), nutritional deficiencies, medications (including chemotherapy), or scarring scalp diseases that permanently destroy follicles. Some causes are temporary and reversible once triggers are addressed, while others require early diagnosis and targeted treatment to prevent permanent loss. There are several factors to consider—see the complete details below for timelines, warning signs, and next steps that could impact your care.

Because hair loss stems from different mechanisms—autoimmune attacks with immune memory (alopecia areata), hormone- and genetics-driven miniaturization (androgenetic alopecia), and scarring that destroys follicles—there isn’t a single, permanent cure. The hair cycle is asynchronous and most treatments only work while used, so relapse is common once they’re stopped. There are several factors to consider that can change your best next step; see below for type-specific details, treatment limits and side effects, and when to seek care.